Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential S1+Docetaxel vs Concomitant S1+Docetaxel in Advanced Gastric Cancer
NCT01718626Phase 2Unknown
- Sponsor
- Hebei Cancer Hospital
- Start
- Oct 2012
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tegafur in gastric cancer (GC), sponsored by Hebei Cancer Hospital. Status: unknown.
02
Drugs
tegafur
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT01718626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01718626.